Voyant Health
Software Solutions for Clinical Orthopedic Workflow
Company Overview
Snapshot
Founded in June 2003, Voyant Health operated with 1–10 employees, specializing in digital imaging workflow solutions for orthopedics. The company was acquired by Brainlab in June 2011, integrating its technology into a broader medical imaging portfolio.
Business overview
Voyant Health develops technology for medical digital-imaging workflow, providing integrated product solutions that streamline how doctors manage and share images and related medical information. The company's core technology focuses on preoperative planning and simulation for orthopedic surgeons, enabling digital templating and surgical planning for joint reconstruction. Voyant Health operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Clinical Workflow, serving healthcare providers in markets such as Germany, the United States, and the United Kingdom.
Strategic signal
In September 2016, TraumaCad sales cemented Brainlab's position as a UK market leader for orthopedic surgical planning. This indicates the continued strategic value and market penetration of Voyant Health's core product, TraumaCad, years after its acquisition, signaling a successful integration and sustained demand for its specialized orthopedic workflow solutions.
Log in to access full profile ›Company Intelligence Q&A
- What is Voyant Health's primary focus?
- Voyant Health develops software solutions for clinical orthopedic workflow, specializing in technology for medical digital-imaging workflow to streamline how doctors work with, manage, and share images and related medical information.
- When was Voyant Health acquired?
- Voyant Health was acquired by Brainlab in June 2011.
- What was the initial market reception for TraumaCad?
- In November 2004, Orthocrat (now Voyant Health) received FDA clearance to market its TraumaCad technology, indicating early regulatory approval and market readiness.
- Has TraumaCad technology been adapted for mobile use?
- Yes, in March 2015, the FDA green-lighted Brainlab's TraumaCad Mobile app, extending the technology's reach to mobile platforms.
- What was a significant product update for TraumaCad prior to the acquisition?
- In June 2009, Orthocrat released Version 2.2 of TraumaCad, demonstrating continuous product development and enhancement.